Skip to main content

Table 2 Agreement of remission and response rates calculated with DAS28(4v)-ESR and DAS28(4v)-CRP at different timepoints after initiating biological therapy

From: Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder

 

κ value

Remission – 3 months

0.689 (P <0.0001)

Remission – 6 months

0.617 (P <0.0001)

Remission – 12 months

0.717 (P <0.0001)

Response – 3 months

0.556 (P <0.0001)

Response – 6 months

0.731 (P <0.0001)

Response – 12 months

0.725 (P <0.0001)

  1. κ value according to Landis and Koch interpretation. DAS28(4v)-ESR, disease activity score based on 28-joint count, erythrocyte sedimentation rate and patient global health, DAS28(4v)-CRP, disease activity score based on 28-joint count, C-reactive protein and patient global health.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us